ルビプロストンの世界市場2019

GlobalInfoResearchが発行した調査報告書（GIR9101821）

◆英語タイトル：Global Lubiprostone Market 2019 by Company, Regions, Type and Application, Forecast to 2024
◆商品コード：GIR9101821
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2019年9月（※2024年版があります。お問い合わせください）
◆ページ数：107
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥515,040	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,220 ⇒換算￥772,560	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,030,080	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、ルビプロストンの世界市場について調べ、まとめました。種類別セグメントは、8 mcgカプセル、24 mcgカプセル等、用途別セグメントは、CICおよびOIC、IBS-C等に区分しました。ルビプロストンの世界市場概観、企業動向、企業別ルビプロストンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・ルビプロストンの市場概観
・ルビプロストンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・ルビプロストンの企業別販売動向、市場シェア、市場集中度、競争動向
・ルビプロストンの世界市場規模
・ルビプロストンの北米市場分析（アメリカ、カナダ、メキシコ等）
・ルビプロストンのアメリカ市場規模推移
・ルビプロストンのカナダ市場規模推移
・ルビプロストンのメキシコ市場規模推移
・ルビプロストンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・ルビプロストンのドイツ市場規模推移
・ルビプロストンのイギリス市場規模推移
・ルビプロストンのロシア市場規模推移
・ルビプロストンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・ルビプロストンの日本市場規模推移
・ルビプロストンの中国市場規模推移
・ルビプロストンの韓国市場規模推移
・ルビプロストンのインド市場規模推移
・ルビプロストンの東南アジア市場規模推移
・ルビプロストンの南米市場分析（ブラジル、アルゼンチン等）
・ルビプロストンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・ルビプロストンの種類別分析/販売量、売上、市場シェア（8 mcgカプセル、24 mcgカプセル）
・ルビプロストンの用途別分析/市場規模（CICおよびOIC、IBS-C）
・ルビプロストンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・ルビプロストンの販売チャネル・代理店・貿易業者・ディーラー分析

【レポートの概要】

Lubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation.

Scope of the Report:
The global Lubiprostone market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lubiprostone.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Lubiprostone market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lubiprostone market by product type and applications/end industries.

Market Segment by Companies, this report covers
Takeda Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
8 mcg Capsules
24 mcg Capsules

Market Segment by Applications, can be divided into
CIC and OIC
IBS-C

【レポートの目次】

Table of Contents

1 Lubiprostone Market Overview
1.1 Product Overview and Scope of Lubiprostone
1.2 Classification of Lubiprostone by Types
1.2.1 Global Lubiprostone Revenue Comparison by Types (2019-2024)
1.2.2 Global Lubiprostone Revenue Market Share by Types in 2018
1.2.3 8 mcg Capsules
1.2.4 24 mcg Capsules
1.3 Global Lubiprostone Market by Application
1.3.1 Global Lubiprostone Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 CIC and OIC
1.3.3 IBS-C
1.4 Global Lubiprostone Market by Regions
1.4.1 Global Lubiprostone Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Lubiprostone Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Lubiprostone Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lubiprostone Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Lubiprostone Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lubiprostone Status and Prospect (2014-2024)
1.5 Global Market Size of Lubiprostone (2014-2024)
2 Manufacturers Profiles
2.1 Takeda Pharmaceuticals
2.1.1 Business Overview
2.1.2 Lubiprostone Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Takeda Pharmaceuticals Lubiprostone Revenue, Gross Margin and Market Share (2017-2018)
3 Global Lubiprostone Market Competition, by Players
3.1 Global Lubiprostone Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Lubiprostone Players Market Share
3.2.2 Top 10 Lubiprostone Players Market Share
3.3 Market Competition Trend
4 Global Lubiprostone Market Size by Regions
4.1 Global Lubiprostone Revenue and Market Share by Regions
4.2 North America Lubiprostone Revenue and Growth Rate (2014-2019)
4.3 Europe Lubiprostone Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Lubiprostone Revenue and Growth Rate (2014-2019)
4.5 South America Lubiprostone Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Lubiprostone Revenue and Growth Rate (2014-2019)
5 North America Lubiprostone Revenue by Countries
5.1 North America Lubiprostone Revenue by Countries (2014-2019)
5.2 USA Lubiprostone Revenue and Growth Rate (2014-2019)
5.3 Canada Lubiprostone Revenue and Growth Rate (2014-2019)
5.4 Mexico Lubiprostone Revenue and Growth Rate (2014-2019)
6 Europe Lubiprostone Revenue by Countries
6.1 Europe Lubiprostone Revenue by Countries (2014-2019)
6.2 Germany Lubiprostone Revenue and Growth Rate (2014-2019)
6.3 UK Lubiprostone Revenue and Growth Rate (2014-2019)
6.4 France Lubiprostone Revenue and Growth Rate (2014-2019)
6.5 Russia Lubiprostone Revenue and Growth Rate (2014-2019)
6.6 Italy Lubiprostone Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Lubiprostone Revenue by Countries
7.1 Asia-Pacific Lubiprostone Revenue by Countries (2014-2019)
7.2 China Lubiprostone Revenue and Growth Rate (2014-2019)
7.3 Japan Lubiprostone Revenue and Growth Rate (2014-2019)
7.4 Korea Lubiprostone Revenue and Growth Rate (2014-2019)
7.5 India Lubiprostone Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Lubiprostone Revenue and Growth Rate (2014-2019)
8 South America Lubiprostone Revenue by Countries
8.1 South America Lubiprostone Revenue by Countries (2014-2019)
8.2 Brazil Lubiprostone Revenue and Growth Rate (2014-2019)
8.3 Argentina Lubiprostone Revenue and Growth Rate (2014-2019)
8.4 Colombia Lubiprostone Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Lubiprostone by Countries
9.1 Middle East and Africa Lubiprostone Revenue by Countries (2014-2019)
9.2 Saudi Arabia Lubiprostone Revenue and Growth Rate (2014-2019)
9.3 UAE Lubiprostone Revenue and Growth Rate (2014-2019)
9.4 Egypt Lubiprostone Revenue and Growth Rate (2014-2019)
9.5 Nigeria Lubiprostone Revenue and Growth Rate (2014-2019)
9.6 South Africa Lubiprostone Revenue and Growth Rate (2014-2019)
10 Global Lubiprostone Market Segment by Type
10.1 Global Lubiprostone Revenue and Market Share by Type (2014-2019)
10.2 Global Lubiprostone Market Forecast by Type (2019-2024)
10.3 8 mcg Capsules Revenue Growth Rate (2014-2024)
10.4 24 mcg Capsules Revenue Growth Rate (2014-2024)
11 Global Lubiprostone Market Segment by Application
11.1 Global Lubiprostone Revenue Market Share by Application (2014-2019)
11.2 Lubiprostone Market Forecast by Application (2019-2024)
11.3 CIC and OIC Revenue Growth (2014-2019)
11.4 IBS-C Revenue Growth (2014-2019)
12 Global Lubiprostone Market Size Forecast (2019-2024)
12.1 Global Lubiprostone Market Size Forecast (2019-2024)
12.2 Global Lubiprostone Market Forecast by Regions (2019-2024)
12.3 North America Lubiprostone Revenue Market Forecast (2019-2024)
12.4 Europe Lubiprostone Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Lubiprostone Revenue Market Forecast (2019-2024)
12.6 South America Lubiprostone Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Lubiprostone Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Lubiprostone Picture
Table Product Specifications of Lubiprostone
Table Global Lubiprostone and Revenue (Million USD) Market Split by Product Type
Figure Global Lubiprostone Revenue Market Share by Types in 2018
Figure 8 mcg Capsules Picture
Figure 24 mcg Capsules Picture
Table Global Lubiprostone Revenue (Million USD) by Application (2014-2024)
Figure Lubiprostone Revenue Market Share by Applications in 2018
Figure CIC and OIC Picture
Figure IBS-C Picture
Table Global Market Lubiprostone Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Lubiprostone Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Lubiprostone Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Lubiprostone Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Lubiprostone Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Lubiprostone Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Lubiprostone Revenue (Million USD) and Growth Rate (2014-2024)
Table Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceuticals Lubiprostone Type and Applications
Table Takeda Pharmaceuticals Lubiprostone Revenue, Gross Margin and Market Share (2017-2018)
Table Global Lubiprostone Revenue (Million USD) by Players (2014-2019)
Table Global Lubiprostone Revenue Share by Players (2014-2019)
Figure Global Lubiprostone Revenue Share by Players in 2017
Figure Global Lubiprostone Revenue Share by Players in 2018
Figure Global Top 5 Players Lubiprostone Revenue Market Share in 2018
Figure Global Top 10 Players Lubiprostone Revenue Market Share in 2018
Figure Global Lubiprostone Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Lubiprostone Revenue (Million USD) by Regions (2014-2019)
Table Global Lubiprostone Revenue Market Share by Regions (2014-2019)
Figure Global Lubiprostone Revenue Market Share by Regions (2014-2019)
Figure Global Lubiprostone Revenue Market Share by Regions in 2018
Figure North America Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Europe Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Lubiprostone Revenue and Growth Rate (2014-2019)
Figure South America Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Lubiprostone Revenue and Growth Rate (2014-2019)
Table North America Lubiprostone Revenue by Countries (2014-2019)
Table North America Lubiprostone Revenue Market Share by Countries (2014-2019)
Figure North America Lubiprostone Revenue Market Share by Countries (2014-2019)
Figure North America Lubiprostone Revenue Market Share by Countries in 2018
Figure USA Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Canada Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Mexico Lubiprostone Revenue and Growth Rate (2014-2019)
Table Europe Lubiprostone Revenue (Million USD) by Countries (2014-2019)
Figure Europe Lubiprostone Revenue Market Share by Countries (2014-2019)
Figure Europe Lubiprostone Revenue Market Share by Countries in 2018
Figure Germany Lubiprostone Revenue and Growth Rate (2014-2019)
Figure UK Lubiprostone Revenue and Growth Rate (2014-2019)
Figure France Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Russia Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Italy Lubiprostone Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Lubiprostone Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Lubiprostone Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Lubiprostone Revenue Market Share by Countries in 2018
Figure China Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Japan Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Korea Lubiprostone Revenue and Growth Rate (2014-2019)
Figure India Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Lubiprostone Revenue and Growth Rate (2014-2019)
Table South America Lubiprostone Revenue by Countries (2014-2019)
Table South America Lubiprostone Revenue Market Share by Countries (2014-2019)
Figure South America Lubiprostone Revenue Market Share by Countries (2014-2019)
Figure South America Lubiprostone Revenue Market Share by Countries in 2018
Figure Brazil Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Argentina Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Colombia Lubiprostone Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Lubiprostone Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Lubiprostone Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Lubiprostone Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Lubiprostone Revenue Market Share by Countries in 2018
Figure Saudi Arabia Lubiprostone Revenue and Growth Rate (2014-2019)
Figure UAE Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Egypt Lubiprostone Revenue and Growth Rate (2014-2019)
Figure Nigeria Lubiprostone Revenue and Growth Rate (2014-2019)
Figure South Africa Lubiprostone Revenue and Growth Rate (2014-2019)
Table Global Lubiprostone Revenue (Million USD) by Type (2014-2019)
Table Global Lubiprostone Revenue Share by Type (2014-2019)
Figure Global Lubiprostone Revenue Share by Type (2014-2019)
Figure Global Lubiprostone Revenue Share by Type in 2019
Table Global Lubiprostone Revenue Forecast by Type (2019-2024)
Figure Global Lubiprostone Market Share Forecast by Type (2019-2024)
Figure Global 8 mcg Capsules Revenue Growth Rate (2014-2019)
Figure Global 24 mcg Capsules Revenue Growth Rate (2014-2019)
Table Global Lubiprostone Revenue by Application (2014-2019)
Table Global Lubiprostone Revenue Share by Application (2014-2019)
Figure Global Lubiprostone Revenue Share by Application (2014-2019)
Figure Global Lubiprostone Revenue Share by Application in 2019
Table Global Lubiprostone Revenue Forecast by Application (2019-2024)
Figure Global Lubiprostone Market Share Forecast by Application (2019-2024)
Figure Global CIC and OIC Revenue Growth Rate (2014-2019)
Figure Global IBS-C Revenue Growth Rate (2014-2019)
Figure Global Lubiprostone Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Lubiprostone Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Lubiprostone Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Lubiprostone Revenue Market Forecast (2019-2024)
Figure Europe Lubiprostone Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Lubiprostone Revenue Market Forecast (2019-2024)
Figure South America Lubiprostone Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Lubiprostone Revenue Market Forecast (2019-2024)

【掲載企業】

Takeda Pharmaceuticals、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ルビプロストンの世界市場2019(Global Lubiprostone Market 2019 by Company, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp